fasano, simone
 Distribuzione geografica
Continente #
NA - Nord America 295
EU - Europa 176
AS - Asia 119
AF - Africa 5
SA - Sud America 5
Totale 600
Nazione #
US - Stati Uniti d'America 294
RU - Federazione Russa 73
SG - Singapore 37
IT - Italia 29
FI - Finlandia 28
CN - Cina 21
HK - Hong Kong 21
VN - Vietnam 19
IE - Irlanda 15
SE - Svezia 10
DE - Germania 7
KR - Corea 7
FR - Francia 5
IN - India 5
ES - Italia 4
BR - Brasile 3
AE - Emirati Arabi Uniti 2
JO - Giordania 2
KE - Kenya 2
PL - Polonia 2
TH - Thailandia 2
AT - Austria 1
CL - Cile 1
CO - Colombia 1
EG - Egitto 1
GB - Regno Unito 1
ID - Indonesia 1
JP - Giappone 1
LY - Libia 1
MX - Messico 1
NL - Olanda 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 600
Città #
Santa Clara 87
Ashburn 28
Singapore 28
Helsinki 26
Hong Kong 20
Chandler 16
Dublin 15
Fairfield 15
Beijing 12
San Jose 12
Woodbridge 10
The Dalles 9
Hanoi 8
Cambridge 7
Houston 7
Milan 7
Moscow 7
Seoul 7
Altamura 6
Buffalo 6
Lawrence 6
Florence 5
Rome 5
Seattle 5
New York 4
Wilmington 4
Boston 3
Council Bluffs 3
Haiphong 3
Ho Chi Minh City 3
Los Angeles 3
Mumbai 3
Munich 3
Paris 3
Princeton 3
Ann Arbor 2
Chicago 2
Falkenstein 2
Johnstown 2
Lauterbourg 2
Nairobi 2
San Diego 2
Yubileyny 2
Amsterdam 1
Andau 1
Andover 1
Aryanah 1
Boardman 1
Brooklyn 1
Cao Lanh 1
Cartagena 1
Chapel Hill 1
Charlotte 1
Da Nang 1
Darnah 1
Delhi 1
Frankfurt am Main 1
Giza 1
Greeley 1
Guangzhou 1
Hillsboro 1
Jacksonville 1
Jakarta 1
Jeddah 1
Juiz de Fora 1
Lappeenranta 1
Maebashi 1
Massillon 1
Medford 1
Miano 1
Ningbo 1
Nuremberg 1
Patna 1
Philadelphia 1
Pietrasanta 1
Pisa 1
Queens 1
Rayong 1
Sam Chuk 1
Santiago de Cali 1
Santos 1
Shenzhen 1
Sterling 1
Stockholm 1
Teófilo Otoni 1
Turku 1
Vũng Tàu 1
Warsaw 1
Winter Garden 1
Wroclaw 1
Totale 452
Nome #
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 231
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 196
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 181
Totale 608
Categoria #
all - tutte 2.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 2 0 5 0 0 1 0 5 3 0 3 8
2022/202369 4 18 3 2 3 12 8 3 11 0 5 0
2023/202423 0 3 2 1 1 6 0 3 1 4 1 1
2024/2025223 5 23 13 35 61 41 4 18 6 8 4 5
2025/2026212 12 16 6 9 27 28 32 18 19 14 10 21
Totale 608